Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AZELNIDIPINE vs AZITHROMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AZELNIDIPINE vs AZITHROMYCIN: Safety Overview

Metric AZELNIDIPINE AZITHROMYCIN
Total FAERS Reports 126 17,553
Deaths Reported 7 1,405
Death Rate 5.6% 8.0%
Hospitalizations 85 5,983
Average Patient Age 64.6 yrs 51.5 yrs
% Female Patients 64.5% 58.6%
FDA Approval Date N/A Apr 11, 2023
Manufacturer N/A DirectRx
Route N/A ORAL
Marketing Status N/A Discontinued